# Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

> **NCT02280590** · PHASE4 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 223 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** Rosuvastatin(Cresnon®)
- **DRUG:** Rosuvastatin(Crestor®)

## Key facts

- **NCT ID:** NCT02280590
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-06
- **Final completion:** —
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02280590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02280590, "Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02280590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*